nodes	percent_of_prediction	percent_of_DWPC	metapath
Ipratropium bromide—CYP2D6—Fingolimod—multiple sclerosis	0.143	0.261	CbGbCtD
Ipratropium bromide—CYP3A4—Fingolimod—multiple sclerosis	0.0908	0.166	CbGbCtD
Ipratropium bromide—CYP3A4—Methylprednisolone—multiple sclerosis	0.0585	0.107	CbGbCtD
Ipratropium bromide—CYP3A4—Triamcinolone—multiple sclerosis	0.0443	0.0811	CbGbCtD
Ipratropium bromide—CYP3A4—Mitoxantrone—multiple sclerosis	0.0427	0.078	CbGbCtD
Ipratropium bromide—CYP3A4—Betamethasone—multiple sclerosis	0.038	0.0695	CbGbCtD
Ipratropium bromide—CYP3A4—Prednisolone—multiple sclerosis	0.0375	0.0686	CbGbCtD
Ipratropium bromide—CYP3A4—Prednisone—multiple sclerosis	0.0354	0.0648	CbGbCtD
Ipratropium bromide—CYP2D6—Dexamethasone—multiple sclerosis	0.0348	0.0636	CbGbCtD
Ipratropium bromide—CYP3A4—Dexamethasone—multiple sclerosis	0.0221	0.0405	CbGbCtD
Ipratropium bromide—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	0.000621	0.00158	CcSEcCtD
Ipratropium bromide—Dysgeusia—Triamcinolone—multiple sclerosis	0.000617	0.00157	CcSEcCtD
Ipratropium bromide—Nausea—Cladribine—multiple sclerosis	0.000616	0.00156	CcSEcCtD
Ipratropium bromide—Eye disorder—Dexamethasone—multiple sclerosis	0.000614	0.00156	CcSEcCtD
Ipratropium bromide—Eye disorder—Betamethasone—multiple sclerosis	0.000614	0.00156	CcSEcCtD
Ipratropium bromide—Paraesthesia—Mitoxantrone—multiple sclerosis	0.000612	0.00155	CcSEcCtD
Ipratropium bromide—Back pain—Triamcinolone—multiple sclerosis	0.000609	0.00155	CcSEcCtD
Ipratropium bromide—Dyspnoea—Mitoxantrone—multiple sclerosis	0.000608	0.00154	CcSEcCtD
Ipratropium bromide—Somnolence—Mitoxantrone—multiple sclerosis	0.000606	0.00154	CcSEcCtD
Ipratropium bromide—Dyspepsia—Mitoxantrone—multiple sclerosis	0.0006	0.00152	CcSEcCtD
Ipratropium bromide—Asthma—Methotrexate—multiple sclerosis	0.000597	0.00152	CcSEcCtD
Ipratropium bromide—Hypertension—Prednisolone—multiple sclerosis	0.000591	0.0015	CcSEcCtD
Ipratropium bromide—Fatigue—Mitoxantrone—multiple sclerosis	0.000588	0.00149	CcSEcCtD
Ipratropium bromide—Constipation—Mitoxantrone—multiple sclerosis	0.000583	0.00148	CcSEcCtD
Ipratropium bromide—Pain—Mitoxantrone—multiple sclerosis	0.000583	0.00148	CcSEcCtD
Ipratropium bromide—Diarrhoea—Azathioprine—multiple sclerosis	0.000577	0.00146	CcSEcCtD
Ipratropium bromide—Angioedema—Triamcinolone—multiple sclerosis	0.000576	0.00146	CcSEcCtD
Ipratropium bromide—Haemoglobin—Prednisone—multiple sclerosis	0.000575	0.00146	CcSEcCtD
Ipratropium bromide—Angioedema—Methylprednisolone—multiple sclerosis	0.000574	0.00146	CcSEcCtD
Ipratropium bromide—Abdominal discomfort—Methotrexate—multiple sclerosis	0.000572	0.00145	CcSEcCtD
Ipratropium bromide—Haemorrhage—Prednisone—multiple sclerosis	0.000572	0.00145	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Prednisolone—multiple sclerosis	0.000559	0.00142	CcSEcCtD
Ipratropium bromide—Oedema—Prednisolone—multiple sclerosis	0.000559	0.00142	CcSEcCtD
Ipratropium bromide—Dysuria—Methotrexate—multiple sclerosis	0.000558	0.00142	CcSEcCtD
Ipratropium bromide—Dizziness—Azathioprine—multiple sclerosis	0.000557	0.00141	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Mitoxantrone—multiple sclerosis	0.000557	0.00141	CcSEcCtD
Ipratropium bromide—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000555	0.00141	CcSEcCtD
Ipratropium bromide—Cough—Triamcinolone—multiple sclerosis	0.00055	0.00139	CcSEcCtD
Ipratropium bromide—Tachycardia—Prednisolone—multiple sclerosis	0.000546	0.00138	CcSEcCtD
Ipratropium bromide—Hypertension—Triamcinolone—multiple sclerosis	0.000544	0.00138	CcSEcCtD
Ipratropium bromide—Hypertension—Methylprednisolone—multiple sclerosis	0.000543	0.00138	CcSEcCtD
Ipratropium bromide—Urticaria—Mitoxantrone—multiple sclerosis	0.000541	0.00137	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00054	0.00137	CcSEcCtD
Ipratropium bromide—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000539	0.00137	CcSEcCtD
Ipratropium bromide—Myalgia—Triamcinolone—multiple sclerosis	0.000536	0.00136	CcSEcCtD
Ipratropium bromide—Vomiting—Azathioprine—multiple sclerosis	0.000536	0.00136	CcSEcCtD
Ipratropium bromide—Myalgia—Methylprednisolone—multiple sclerosis	0.000535	0.00136	CcSEcCtD
Ipratropium bromide—Eye disorder—Prednisone—multiple sclerosis	0.000534	0.00136	CcSEcCtD
Ipratropium bromide—Rash—Azathioprine—multiple sclerosis	0.000532	0.00135	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.000531	0.00135	CcSEcCtD
Ipratropium bromide—Dermatitis—Azathioprine—multiple sclerosis	0.000531	0.00135	CcSEcCtD
Ipratropium bromide—Flushing—Prednisone—multiple sclerosis	0.000531	0.00135	CcSEcCtD
Ipratropium bromide—Headache—Azathioprine—multiple sclerosis	0.000528	0.00134	CcSEcCtD
Ipratropium bromide—Dry mouth—Triamcinolone—multiple sclerosis	0.000525	0.00133	CcSEcCtD
Ipratropium bromide—Angioedema—Dexamethasone—multiple sclerosis	0.000522	0.00133	CcSEcCtD
Ipratropium bromide—Angioedema—Betamethasone—multiple sclerosis	0.000522	0.00133	CcSEcCtD
Ipratropium bromide—Stomatitis—Methotrexate—multiple sclerosis	0.000519	0.00132	CcSEcCtD
Ipratropium bromide—Conjunctivitis—Methotrexate—multiple sclerosis	0.000517	0.00131	CcSEcCtD
Ipratropium bromide—Immune system disorder—Prednisone—multiple sclerosis	0.000517	0.00131	CcSEcCtD
Ipratropium bromide—Oedema—Triamcinolone—multiple sclerosis	0.000514	0.0013	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000514	0.0013	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000513	0.0013	CcSEcCtD
Ipratropium bromide—Infection—Triamcinolone—multiple sclerosis	0.000511	0.0013	CcSEcCtD
Ipratropium bromide—Sweating—Methotrexate—multiple sclerosis	0.00051	0.0013	CcSEcCtD
Ipratropium bromide—Infection—Methylprednisolone—multiple sclerosis	0.00051	0.00129	CcSEcCtD
Ipratropium bromide—Insomnia—Prednisolone—multiple sclerosis	0.000506	0.00128	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.000503	0.00128	CcSEcCtD
Ipratropium bromide—Epistaxis—Methotrexate—multiple sclerosis	0.000502	0.00127	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.000502	0.00127	CcSEcCtD
Ipratropium bromide—Paraesthesia—Prednisolone—multiple sclerosis	0.000502	0.00127	CcSEcCtD
Ipratropium bromide—Tachycardia—Triamcinolone—multiple sclerosis	0.000502	0.00127	CcSEcCtD
Ipratropium bromide—Nausea—Azathioprine—multiple sclerosis	0.000501	0.00127	CcSEcCtD
Ipratropium bromide—Tachycardia—Methylprednisolone—multiple sclerosis	0.000501	0.00127	CcSEcCtD
Ipratropium bromide—Skin disorder—Methylprednisolone—multiple sclerosis	0.000498	0.00126	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000497	0.00126	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000496	0.00126	CcSEcCtD
Ipratropium bromide—Hypertension—Betamethasone—multiple sclerosis	0.000494	0.00125	CcSEcCtD
Ipratropium bromide—Hypertension—Dexamethasone—multiple sclerosis	0.000494	0.00125	CcSEcCtD
Ipratropium bromide—Asthenia—Mitoxantrone—multiple sclerosis	0.000489	0.00124	CcSEcCtD
Ipratropium bromide—Myalgia—Dexamethasone—multiple sclerosis	0.000487	0.00123	CcSEcCtD
Ipratropium bromide—Myalgia—Betamethasone—multiple sclerosis	0.000487	0.00123	CcSEcCtD
Ipratropium bromide—Haemoglobin—Methotrexate—multiple sclerosis	0.00048	0.00122	CcSEcCtD
Ipratropium bromide—Hypotension—Methylprednisolone—multiple sclerosis	0.000479	0.00122	CcSEcCtD
Ipratropium bromide—Pain—Prednisolone—multiple sclerosis	0.000478	0.00121	CcSEcCtD
Ipratropium bromide—Haemorrhage—Methotrexate—multiple sclerosis	0.000478	0.00121	CcSEcCtD
Ipratropium bromide—Pharyngitis—Methotrexate—multiple sclerosis	0.000474	0.0012	CcSEcCtD
Ipratropium bromide—Urinary tract disorder—Methotrexate—multiple sclerosis	0.000472	0.0012	CcSEcCtD
Ipratropium bromide—Vision blurred—Prednisone—multiple sclerosis	0.000469	0.00119	CcSEcCtD
Ipratropium bromide—Urethral disorder—Methotrexate—multiple sclerosis	0.000468	0.00119	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000468	0.00119	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000467	0.00119	CcSEcCtD
Ipratropium bromide—Oedema—Betamethasone—multiple sclerosis	0.000467	0.00118	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000467	0.00118	CcSEcCtD
Ipratropium bromide—Oedema—Dexamethasone—multiple sclerosis	0.000467	0.00118	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000467	0.00118	CcSEcCtD
Ipratropium bromide—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000466	0.00118	CcSEcCtD
Ipratropium bromide—Insomnia—Triamcinolone—multiple sclerosis	0.000465	0.00118	CcSEcCtD
Ipratropium bromide—Insomnia—Methylprednisolone—multiple sclerosis	0.000464	0.00118	CcSEcCtD
Ipratropium bromide—Infection—Dexamethasone—multiple sclerosis	0.000463	0.00118	CcSEcCtD
Ipratropium bromide—Infection—Betamethasone—multiple sclerosis	0.000463	0.00118	CcSEcCtD
Ipratropium bromide—Paraesthesia—Triamcinolone—multiple sclerosis	0.000462	0.00117	CcSEcCtD
Ipratropium bromide—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000461	0.00117	CcSEcCtD
Ipratropium bromide—Visual impairment—Methotrexate—multiple sclerosis	0.000461	0.00117	CcSEcCtD
Ipratropium bromide—Dyspnoea—Triamcinolone—multiple sclerosis	0.000458	0.00116	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Betamethasone—multiple sclerosis	0.000457	0.00116	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000457	0.00116	CcSEcCtD
Ipratropium bromide—Tachycardia—Dexamethasone—multiple sclerosis	0.000455	0.00116	CcSEcCtD
Ipratropium bromide—Tachycardia—Betamethasone—multiple sclerosis	0.000455	0.00116	CcSEcCtD
Ipratropium bromide—Angioedema—Prednisone—multiple sclerosis	0.000455	0.00115	CcSEcCtD
Ipratropium bromide—Dyspepsia—Triamcinolone—multiple sclerosis	0.000453	0.00115	CcSEcCtD
Ipratropium bromide—Dyspepsia—Methylprednisolone—multiple sclerosis	0.000452	0.00115	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000451	0.00114	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000451	0.00114	CcSEcCtD
Ipratropium bromide—Eye disorder—Methotrexate—multiple sclerosis	0.000447	0.00113	CcSEcCtD
Ipratropium bromide—Tinnitus—Methotrexate—multiple sclerosis	0.000446	0.00113	CcSEcCtD
Ipratropium bromide—Urticaria—Prednisolone—multiple sclerosis	0.000444	0.00113	CcSEcCtD
Ipratropium bromide—Cardiac disorder—Methotrexate—multiple sclerosis	0.000444	0.00113	CcSEcCtD
Ipratropium bromide—Fatigue—Triamcinolone—multiple sclerosis	0.000443	0.00112	CcSEcCtD
Ipratropium bromide—Fatigue—Methylprednisolone—multiple sclerosis	0.000442	0.00112	CcSEcCtD
Ipratropium bromide—Pain—Triamcinolone—multiple sclerosis	0.00044	0.00112	CcSEcCtD
Ipratropium bromide—Hypotension—Betamethasone—multiple sclerosis	0.000436	0.00111	CcSEcCtD
Ipratropium bromide—Hypotension—Dexamethasone—multiple sclerosis	0.000436	0.00111	CcSEcCtD
Ipratropium bromide—Vomiting—Mitoxantrone—multiple sclerosis	0.000433	0.0011	CcSEcCtD
Ipratropium bromide—Immune system disorder—Methotrexate—multiple sclerosis	0.000432	0.0011	CcSEcCtD
Ipratropium bromide—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000431	0.00109	CcSEcCtD
Ipratropium bromide—Hypertension—Prednisone—multiple sclerosis	0.00043	0.00109	CcSEcCtD
Ipratropium bromide—Rash—Mitoxantrone—multiple sclerosis	0.00043	0.00109	CcSEcCtD
Ipratropium bromide—Dermatitis—Mitoxantrone—multiple sclerosis	0.000429	0.00109	CcSEcCtD
Ipratropium bromide—Headache—Mitoxantrone—multiple sclerosis	0.000427	0.00108	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.000425	0.00108	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.000425	0.00108	CcSEcCtD
Ipratropium bromide—Myalgia—Prednisone—multiple sclerosis	0.000424	0.00108	CcSEcCtD
Ipratropium bromide—Insomnia—Dexamethasone—multiple sclerosis	0.000422	0.00107	CcSEcCtD
Ipratropium bromide—Insomnia—Betamethasone—multiple sclerosis	0.000422	0.00107	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000421	0.00107	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000419	0.00106	CcSEcCtD
Ipratropium bromide—Paraesthesia—Dexamethasone—multiple sclerosis	0.000419	0.00106	CcSEcCtD
Ipratropium bromide—Paraesthesia—Betamethasone—multiple sclerosis	0.000419	0.00106	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Prednisolone—multiple sclerosis	0.000412	0.00105	CcSEcCtD
Ipratropium bromide—Dyspepsia—Betamethasone—multiple sclerosis	0.000411	0.00104	CcSEcCtD
Ipratropium bromide—Dyspepsia—Dexamethasone—multiple sclerosis	0.000411	0.00104	CcSEcCtD
Ipratropium bromide—Urticaria—Triamcinolone—multiple sclerosis	0.000408	0.00104	CcSEcCtD
Ipratropium bromide—Urticaria—Methylprednisolone—multiple sclerosis	0.000408	0.00103	CcSEcCtD
Ipratropium bromide—Dysgeusia—Methotrexate—multiple sclerosis	0.000407	0.00103	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Prednisone—multiple sclerosis	0.000406	0.00103	CcSEcCtD
Ipratropium bromide—Oedema—Prednisone—multiple sclerosis	0.000406	0.00103	CcSEcCtD
Ipratropium bromide—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000406	0.00103	CcSEcCtD
Ipratropium bromide—Nausea—Mitoxantrone—multiple sclerosis	0.000405	0.00103	CcSEcCtD
Ipratropium bromide—Infection—Prednisone—multiple sclerosis	0.000404	0.00102	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.000403	0.00102	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.000403	0.00102	CcSEcCtD
Ipratropium bromide—Back pain—Methotrexate—multiple sclerosis	0.000402	0.00102	CcSEcCtD
Ipratropium bromide—Fatigue—Betamethasone—multiple sclerosis	0.000402	0.00102	CcSEcCtD
Ipratropium bromide—Fatigue—Dexamethasone—multiple sclerosis	0.000402	0.00102	CcSEcCtD
Ipratropium bromide—Pain—Dexamethasone—multiple sclerosis	0.000399	0.00101	CcSEcCtD
Ipratropium bromide—Pain—Betamethasone—multiple sclerosis	0.000399	0.00101	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Prednisone—multiple sclerosis	0.000398	0.00101	CcSEcCtD
Ipratropium bromide—Tachycardia—Prednisone—multiple sclerosis	0.000397	0.00101	CcSEcCtD
Ipratropium bromide—Skin disorder—Prednisone—multiple sclerosis	0.000395	0.001	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Prednisone—multiple sclerosis	0.000393	0.000997	CcSEcCtD
Ipratropium bromide—Vision blurred—Methotrexate—multiple sclerosis	0.000392	0.000995	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000381	0.000968	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000381	0.000968	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Triamcinolone—multiple sclerosis	0.000379	0.000961	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000378	0.000959	CcSEcCtD
Ipratropium bromide—Urticaria—Dexamethasone—multiple sclerosis	0.000371	0.00094	CcSEcCtD
Ipratropium bromide—Urticaria—Betamethasone—multiple sclerosis	0.000371	0.00094	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.00037	0.000939	CcSEcCtD
Ipratropium bromide—Dizziness—Prednisolone—multiple sclerosis	0.00037	0.000938	CcSEcCtD
Ipratropium bromide—Asthenia—Triamcinolone—multiple sclerosis	0.000369	0.000936	CcSEcCtD
Ipratropium bromide—Abdominal pain—Betamethasone—multiple sclerosis	0.000369	0.000936	CcSEcCtD
Ipratropium bromide—Abdominal pain—Dexamethasone—multiple sclerosis	0.000369	0.000936	CcSEcCtD
Ipratropium bromide—Asthenia—Methylprednisolone—multiple sclerosis	0.000368	0.000934	CcSEcCtD
Ipratropium bromide—Insomnia—Prednisone—multiple sclerosis	0.000367	0.000932	CcSEcCtD
Ipratropium bromide—Paraesthesia—Prednisone—multiple sclerosis	0.000365	0.000926	CcSEcCtD
Ipratropium bromide—Pruritus—Triamcinolone—multiple sclerosis	0.000364	0.000923	CcSEcCtD
Ipratropium bromide—Cough—Methotrexate—multiple sclerosis	0.000363	0.000921	CcSEcCtD
Ipratropium bromide—Pruritus—Methylprednisolone—multiple sclerosis	0.000363	0.000921	CcSEcCtD
Ipratropium bromide—Dyspepsia—Prednisone—multiple sclerosis	0.000358	0.000908	CcSEcCtD
Ipratropium bromide—Myalgia—Methotrexate—multiple sclerosis	0.000354	0.000899	CcSEcCtD
Ipratropium bromide—Chest pain—Methotrexate—multiple sclerosis	0.000354	0.000899	CcSEcCtD
Ipratropium bromide—Rash—Prednisolone—multiple sclerosis	0.000353	0.000895	CcSEcCtD
Ipratropium bromide—Dermatitis—Prednisolone—multiple sclerosis	0.000352	0.000894	CcSEcCtD
Ipratropium bromide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000352	0.000893	CcSEcCtD
Ipratropium bromide—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000351	0.000891	CcSEcCtD
Ipratropium bromide—Fatigue—Prednisone—multiple sclerosis	0.00035	0.000889	CcSEcCtD
Ipratropium bromide—Headache—Prednisolone—multiple sclerosis	0.00035	0.000889	CcSEcCtD
Ipratropium bromide—Constipation—Prednisone—multiple sclerosis	0.000347	0.000882	CcSEcCtD
Ipratropium bromide—Dizziness—Triamcinolone—multiple sclerosis	0.00034	0.000863	CcSEcCtD
Ipratropium bromide—Anaphylactic shock—Methotrexate—multiple sclerosis	0.00034	0.000862	CcSEcCtD
Ipratropium bromide—Dizziness—Methylprednisolone—multiple sclerosis	0.000339	0.000861	CcSEcCtD
Ipratropium bromide—Infection—Methotrexate—multiple sclerosis	0.000337	0.000856	CcSEcCtD
Ipratropium bromide—Asthenia—Dexamethasone—multiple sclerosis	0.000335	0.000849	CcSEcCtD
Ipratropium bromide—Asthenia—Betamethasone—multiple sclerosis	0.000335	0.000849	CcSEcCtD
Ipratropium bromide—Nervous system disorder—Methotrexate—multiple sclerosis	0.000333	0.000845	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000332	0.000843	CcSEcCtD
Ipratropium bromide—Nausea—Prednisolone—multiple sclerosis	0.000332	0.000843	CcSEcCtD
Ipratropium bromide—Pruritus—Dexamethasone—multiple sclerosis	0.00033	0.000838	CcSEcCtD
Ipratropium bromide—Pruritus—Betamethasone—multiple sclerosis	0.00033	0.000838	CcSEcCtD
Ipratropium bromide—Skin disorder—Methotrexate—multiple sclerosis	0.00033	0.000837	CcSEcCtD
Ipratropium bromide—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000328	0.000833	CcSEcCtD
Ipratropium bromide—Vomiting—Triamcinolone—multiple sclerosis	0.000327	0.00083	CcSEcCtD
Ipratropium bromide—Vomiting—Methylprednisolone—multiple sclerosis	0.000326	0.000828	CcSEcCtD
Ipratropium bromide—Rash—Triamcinolone—multiple sclerosis	0.000324	0.000823	CcSEcCtD
Ipratropium bromide—Dermatitis—Triamcinolone—multiple sclerosis	0.000324	0.000822	CcSEcCtD
Ipratropium bromide—Rash—Methylprednisolone—multiple sclerosis	0.000323	0.000821	CcSEcCtD
Ipratropium bromide—Dermatitis—Methylprednisolone—multiple sclerosis	0.000323	0.00082	CcSEcCtD
Ipratropium bromide—Urticaria—Prednisone—multiple sclerosis	0.000323	0.000819	CcSEcCtD
Ipratropium bromide—Headache—Triamcinolone—multiple sclerosis	0.000322	0.000817	CcSEcCtD
Ipratropium bromide—Headache—Methylprednisolone—multiple sclerosis	0.000321	0.000816	CcSEcCtD
Ipratropium bromide—Abdominal pain—Prednisone—multiple sclerosis	0.000321	0.000815	CcSEcCtD
Ipratropium bromide—Diarrhoea—Betamethasone—multiple sclerosis	0.000319	0.00081	CcSEcCtD
Ipratropium bromide—Diarrhoea—Dexamethasone—multiple sclerosis	0.000319	0.00081	CcSEcCtD
Ipratropium bromide—Hypotension—Methotrexate—multiple sclerosis	0.000317	0.000805	CcSEcCtD
Ipratropium bromide—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000309	0.000785	CcSEcCtD
Ipratropium bromide—Dizziness—Betamethasone—multiple sclerosis	0.000308	0.000783	CcSEcCtD
Ipratropium bromide—Dizziness—Dexamethasone—multiple sclerosis	0.000308	0.000783	CcSEcCtD
Ipratropium bromide—Insomnia—Methotrexate—multiple sclerosis	0.000307	0.000779	CcSEcCtD
Ipratropium bromide—Nausea—Triamcinolone—multiple sclerosis	0.000305	0.000775	CcSEcCtD
Ipratropium bromide—Paraesthesia—Methotrexate—multiple sclerosis	0.000305	0.000774	CcSEcCtD
Ipratropium bromide—Nausea—Methylprednisolone—multiple sclerosis	0.000305	0.000773	CcSEcCtD
Ipratropium bromide—Dyspnoea—Methotrexate—multiple sclerosis	0.000303	0.000768	CcSEcCtD
Ipratropium bromide—Somnolence—Methotrexate—multiple sclerosis	0.000302	0.000766	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Prednisone—multiple sclerosis	0.000299	0.00076	CcSEcCtD
Ipratropium bromide—Dyspepsia—Methotrexate—multiple sclerosis	0.000299	0.000758	CcSEcCtD
Ipratropium bromide—Vomiting—Dexamethasone—multiple sclerosis	0.000297	0.000753	CcSEcCtD
Ipratropium bromide—Vomiting—Betamethasone—multiple sclerosis	0.000297	0.000753	CcSEcCtD
Ipratropium bromide—Rash—Betamethasone—multiple sclerosis	0.000294	0.000746	CcSEcCtD
Ipratropium bromide—Rash—Dexamethasone—multiple sclerosis	0.000294	0.000746	CcSEcCtD
Ipratropium bromide—Dermatitis—Dexamethasone—multiple sclerosis	0.000294	0.000746	CcSEcCtD
Ipratropium bromide—Dermatitis—Betamethasone—multiple sclerosis	0.000294	0.000746	CcSEcCtD
Ipratropium bromide—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000293	0.000744	CcSEcCtD
Ipratropium bromide—Fatigue—Methotrexate—multiple sclerosis	0.000293	0.000743	CcSEcCtD
Ipratropium bromide—Headache—Betamethasone—multiple sclerosis	0.000292	0.000742	CcSEcCtD
Ipratropium bromide—Headache—Dexamethasone—multiple sclerosis	0.000292	0.000742	CcSEcCtD
Ipratropium bromide—Asthenia—Prednisone—multiple sclerosis	0.000291	0.00074	CcSEcCtD
Ipratropium bromide—Pain—Methotrexate—multiple sclerosis	0.00029	0.000737	CcSEcCtD
Ipratropium bromide—Pruritus—Prednisone—multiple sclerosis	0.000287	0.000729	CcSEcCtD
Ipratropium bromide—Diarrhoea—Prednisone—multiple sclerosis	0.000278	0.000705	CcSEcCtD
Ipratropium bromide—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000278	0.000705	CcSEcCtD
Ipratropium bromide—Nausea—Dexamethasone—multiple sclerosis	0.000277	0.000703	CcSEcCtD
Ipratropium bromide—Nausea—Betamethasone—multiple sclerosis	0.000277	0.000703	CcSEcCtD
Ipratropium bromide—Urticaria—Methotrexate—multiple sclerosis	0.00027	0.000684	CcSEcCtD
Ipratropium bromide—Dizziness—Prednisone—multiple sclerosis	0.000269	0.000682	CcSEcCtD
Ipratropium bromide—Abdominal pain—Methotrexate—multiple sclerosis	0.000268	0.000681	CcSEcCtD
Ipratropium bromide—Vomiting—Prednisone—multiple sclerosis	0.000258	0.000655	CcSEcCtD
Ipratropium bromide—Rash—Prednisone—multiple sclerosis	0.000256	0.00065	CcSEcCtD
Ipratropium bromide—Dermatitis—Prednisone—multiple sclerosis	0.000256	0.000649	CcSEcCtD
Ipratropium bromide—Headache—Prednisone—multiple sclerosis	0.000255	0.000646	CcSEcCtD
Ipratropium bromide—Hypersensitivity—Methotrexate—multiple sclerosis	0.00025	0.000635	CcSEcCtD
Ipratropium bromide—Asthenia—Methotrexate—multiple sclerosis	0.000244	0.000618	CcSEcCtD
Ipratropium bromide—Nausea—Prednisone—multiple sclerosis	0.000241	0.000612	CcSEcCtD
Ipratropium bromide—Pruritus—Methotrexate—multiple sclerosis	0.00024	0.00061	CcSEcCtD
Ipratropium bromide—Diarrhoea—Methotrexate—multiple sclerosis	0.000232	0.00059	CcSEcCtD
Ipratropium bromide—Dizziness—Methotrexate—multiple sclerosis	0.000225	0.00057	CcSEcCtD
Ipratropium bromide—Vomiting—Methotrexate—multiple sclerosis	0.000216	0.000548	CcSEcCtD
Ipratropium bromide—Rash—Methotrexate—multiple sclerosis	0.000214	0.000543	CcSEcCtD
Ipratropium bromide—Dermatitis—Methotrexate—multiple sclerosis	0.000214	0.000543	CcSEcCtD
Ipratropium bromide—Headache—Methotrexate—multiple sclerosis	0.000213	0.00054	CcSEcCtD
Ipratropium bromide—Nausea—Methotrexate—multiple sclerosis	0.000202	0.000512	CcSEcCtD
Ipratropium bromide—CHRM1—GPCR ligand binding—CCR5—multiple sclerosis	5.48e-05	0.000929	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—CCR5—multiple sclerosis	5.46e-05	0.000926	CbGpPWpGaD
Ipratropium bromide—CHRM2—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	5.43e-05	0.00092	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—S1PR1—multiple sclerosis	5.43e-05	0.00092	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Biological oxidations—POMC—multiple sclerosis	5.41e-05	0.000917	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—CCR5—multiple sclerosis	5.41e-05	0.000917	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—S1PR1—multiple sclerosis	5.41e-05	0.000917	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—S1PR1—multiple sclerosis	5.36e-05	0.000908	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—GPC5—multiple sclerosis	5.28e-05	0.000894	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GPC5—multiple sclerosis	5.26e-05	0.000892	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—TNF—multiple sclerosis	5.22e-05	0.000884	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—RRM1—multiple sclerosis	5.22e-05	0.000884	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GPC5—multiple sclerosis	5.21e-05	0.000883	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—CXCL10—multiple sclerosis	5.15e-05	0.000873	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—PTGER4—multiple sclerosis	5.12e-05	0.000867	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—PTGER4—multiple sclerosis	5.1e-05	0.000864	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—PTGER4—multiple sclerosis	5.05e-05	0.000856	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CXCR3—multiple sclerosis	4.94e-05	0.000837	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CXCR3—multiple sclerosis	4.93e-05	0.000834	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—CCL5—multiple sclerosis	4.88e-05	0.000827	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CXCR3—multiple sclerosis	4.88e-05	0.000826	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CCL3—multiple sclerosis	4.83e-05	0.000818	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CCL3—multiple sclerosis	4.81e-05	0.000815	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CCR2—multiple sclerosis	4.81e-05	0.000814	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CCR2—multiple sclerosis	4.79e-05	0.000812	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CCL3—multiple sclerosis	4.77e-05	0.000807	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CCR2—multiple sclerosis	4.75e-05	0.000804	CbGpPWpGaD
Ipratropium bromide—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	4.69e-05	0.000794	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—PTGER4—multiple sclerosis	4.65e-05	0.000787	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—PTGER4—multiple sclerosis	4.63e-05	0.000785	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—RGS1—multiple sclerosis	4.62e-05	0.000782	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—RGS1—multiple sclerosis	4.6e-05	0.000779	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—PTGER4—multiple sclerosis	4.59e-05	0.000777	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—RGS1—multiple sclerosis	4.56e-05	0.000772	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CXCR3—multiple sclerosis	4.49e-05	0.00076	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CXCR3—multiple sclerosis	4.47e-05	0.000758	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CNR1—multiple sclerosis	4.44e-05	0.000751	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—CCL5—multiple sclerosis	4.44e-05	0.000751	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CXCR3—multiple sclerosis	4.43e-05	0.00075	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CNR1—multiple sclerosis	4.42e-05	0.000749	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—CCR5—multiple sclerosis	4.4e-05	0.000745	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CNR1—multiple sclerosis	4.38e-05	0.000742	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—GPR65—multiple sclerosis	4.38e-05	0.000741	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CCR2—multiple sclerosis	4.37e-05	0.000739	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—GPR65—multiple sclerosis	4.36e-05	0.000739	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CCR2—multiple sclerosis	4.35e-05	0.000737	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—IL2RA—multiple sclerosis	4.34e-05	0.000734	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—GPR65—multiple sclerosis	4.32e-05	0.000732	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CCR2—multiple sclerosis	4.31e-05	0.00073	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.3e-05	0.000728	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—POMC—multiple sclerosis	4.28e-05	0.000726	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	4.28e-05	0.000725	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—POMC—multiple sclerosis	4.27e-05	0.000723	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—POMC—multiple sclerosis	4.23e-05	0.000716	CbGpPWpGaD
Ipratropium bromide—CHRM2—SIDS Susceptibility Pathways—IL6—multiple sclerosis	4.21e-05	0.000714	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR ligand binding—CCL2—multiple sclerosis	4.19e-05	0.00071	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR ligand binding—CCL2—multiple sclerosis	4.18e-05	0.000708	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR ligand binding—CCL2—multiple sclerosis	4.14e-05	0.000701	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP24A1—multiple sclerosis	4.12e-05	0.000697	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—CYP27B1—multiple sclerosis	4.12e-05	0.000697	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCL3—multiple sclerosis	4.05e-05	0.000686	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CNR1—multiple sclerosis	4.03e-05	0.000682	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CNR1—multiple sclerosis	4.02e-05	0.00068	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CXCL13—multiple sclerosis	4e-05	0.000678	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCR1—multiple sclerosis	4e-05	0.000678	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—CCR5—multiple sclerosis	4e-05	0.000677	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CXCL10—multiple sclerosis	4e-05	0.000677	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CXCL13—multiple sclerosis	3.99e-05	0.000676	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCR1—multiple sclerosis	3.99e-05	0.000676	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CXCL10—multiple sclerosis	3.98e-05	0.000674	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CNR1—multiple sclerosis	3.98e-05	0.000674	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCR1—multiple sclerosis	3.95e-05	0.000669	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CXCL13—multiple sclerosis	3.95e-05	0.000669	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CXCL10—multiple sclerosis	3.94e-05	0.000668	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL2RA—multiple sclerosis	3.94e-05	0.000667	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PTGER4—multiple sclerosis	3.9e-05	0.00066	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—PGR—multiple sclerosis	3.84e-05	0.00065	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—SRM—multiple sclerosis	3.82e-05	0.000647	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CXCR3—multiple sclerosis	3.77e-05	0.000638	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—GPC5—multiple sclerosis	3.76e-05	0.000638	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CD28—multiple sclerosis	3.73e-05	0.000632	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCR2—multiple sclerosis	3.66e-05	0.00062	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CXCL10—multiple sclerosis	3.63e-05	0.000614	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CXCL10—multiple sclerosis	3.62e-05	0.000612	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CXCL10—multiple sclerosis	3.58e-05	0.000607	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.54e-05	0.0006	CbGpPWpGaD
Ipratropium bromide—CHRM1—Circadian rythm related genes—IL6—multiple sclerosis	3.48e-05	0.00059	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—POMC—multiple sclerosis	3.44e-05	0.000582	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CCL5—multiple sclerosis	3.44e-05	0.000582	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CCL5—multiple sclerosis	3.43e-05	0.000581	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CCL5—multiple sclerosis	3.39e-05	0.000575	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CNR1—multiple sclerosis	3.38e-05	0.000573	CbGpPWpGaD
Ipratropium bromide—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.3e-05	0.000559	CbGpPWpGaD
Ipratropium bromide—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	3.29e-05	0.000557	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CCL5—multiple sclerosis	3.12e-05	0.000529	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—POMC—multiple sclerosis	3.12e-05	0.000529	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—RRM1—multiple sclerosis	3.12e-05	0.000528	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CCL5—multiple sclerosis	3.11e-05	0.000527	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—CCR5—multiple sclerosis	3.1e-05	0.000525	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—CCR5—multiple sclerosis	3.09e-05	0.000523	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CCL5—multiple sclerosis	3.08e-05	0.000522	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—CCR5—multiple sclerosis	3.06e-05	0.000518	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—CCL2—multiple sclerosis	3.06e-05	0.000518	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—IL2RA—multiple sclerosis	3.05e-05	0.000517	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CXCL10—multiple sclerosis	3.04e-05	0.000516	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—IL2RA—multiple sclerosis	3.04e-05	0.000516	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—IL2RA—multiple sclerosis	3.01e-05	0.000511	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—BCHE—multiple sclerosis	3e-05	0.000507	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCL3—multiple sclerosis	2.85e-05	0.000483	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCL3—multiple sclerosis	2.84e-05	0.000481	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCL3—multiple sclerosis	2.82e-05	0.000477	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CCR5—multiple sclerosis	2.81e-05	0.000477	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CCR5—multiple sclerosis	2.8e-05	0.000475	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CCR5—multiple sclerosis	2.78e-05	0.00047	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—TYK2—multiple sclerosis	2.77e-05	0.00047	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL2RA—multiple sclerosis	2.77e-05	0.00047	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL2RA—multiple sclerosis	2.76e-05	0.000468	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PTGER4—multiple sclerosis	2.75e-05	0.000465	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL2RA—multiple sclerosis	2.74e-05	0.000464	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PTGER4—multiple sclerosis	2.74e-05	0.000463	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PTGER4—multiple sclerosis	2.71e-05	0.000459	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—PGR—multiple sclerosis	2.7e-05	0.000458	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—PGR—multiple sclerosis	2.7e-05	0.000456	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.69e-05	0.000456	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.69e-05	0.000456	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—PGR—multiple sclerosis	2.67e-05	0.000452	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CD86—multiple sclerosis	2.66e-05	0.000451	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CXCR3—multiple sclerosis	2.65e-05	0.000449	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CXCR3—multiple sclerosis	2.64e-05	0.000448	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CD28—multiple sclerosis	2.63e-05	0.000445	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCL5—multiple sclerosis	2.62e-05	0.000444	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CD28—multiple sclerosis	2.62e-05	0.000443	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CXCR3—multiple sclerosis	2.62e-05	0.000443	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CD28—multiple sclerosis	2.59e-05	0.000439	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCR2—multiple sclerosis	2.58e-05	0.000437	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCR2—multiple sclerosis	2.57e-05	0.000435	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCR2—multiple sclerosis	2.55e-05	0.000431	CbGpPWpGaD
Ipratropium bromide—CHRM5—GPCR downstream signaling—IL2—multiple sclerosis	2.54e-05	0.000431	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.46e-05	0.000417	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—SPP1—multiple sclerosis	2.43e-05	0.000411	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—POMC—multiple sclerosis	2.42e-05	0.00041	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—POMC—multiple sclerosis	2.41e-05	0.000409	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—POMC—multiple sclerosis	2.39e-05	0.000405	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CNR1—multiple sclerosis	2.38e-05	0.000403	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CNR1—multiple sclerosis	2.37e-05	0.000402	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCR5—multiple sclerosis	2.36e-05	0.0004	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CNR1—multiple sclerosis	2.35e-05	0.000398	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL2RA—multiple sclerosis	2.33e-05	0.000394	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL2—multiple sclerosis	2.31e-05	0.000391	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—POMC—multiple sclerosis	2.2e-05	0.000372	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—POMC—multiple sclerosis	2.19e-05	0.000371	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—POMC—multiple sclerosis	2.17e-05	0.000368	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—CCL2—multiple sclerosis	2.15e-05	0.000364	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—APOE—multiple sclerosis	2.15e-05	0.000364	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—CCL2—multiple sclerosis	2.14e-05	0.000363	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CXCL10—multiple sclerosis	2.14e-05	0.000363	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CXCL10—multiple sclerosis	2.14e-05	0.000362	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—CCL2—multiple sclerosis	2.12e-05	0.00036	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CXCL10—multiple sclerosis	2.12e-05	0.000358	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.04e-05	0.000345	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—TYK2—multiple sclerosis	1.95e-05	0.000331	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—TYK2—multiple sclerosis	1.95e-05	0.00033	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CD80—multiple sclerosis	1.94e-05	0.000329	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—TYK2—multiple sclerosis	1.93e-05	0.000327	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CD86—multiple sclerosis	1.87e-05	0.000317	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CD86—multiple sclerosis	1.87e-05	0.000316	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CD86—multiple sclerosis	1.85e-05	0.000313	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—POMC—multiple sclerosis	1.84e-05	0.000312	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCL5—multiple sclerosis	1.84e-05	0.000312	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCL5—multiple sclerosis	1.84e-05	0.000311	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCL5—multiple sclerosis	1.82e-05	0.000308	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—CCL2—multiple sclerosis	1.81e-05	0.000306	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—APOE—multiple sclerosis	1.8e-05	0.000305	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—BCHE—multiple sclerosis	1.79e-05	0.000303	CbGpPWpGaD
Ipratropium bromide—CHRM1—GPCR downstream signaling—IL2—multiple sclerosis	1.79e-05	0.000303	CbGpPWpGaD
Ipratropium bromide—CHRM3—GPCR downstream signaling—IL2—multiple sclerosis	1.78e-05	0.000302	CbGpPWpGaD
Ipratropium bromide—CHRM2—GPCR downstream signaling—IL2—multiple sclerosis	1.77e-05	0.000299	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—MAPK1—multiple sclerosis	1.77e-05	0.000299	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—SPP1—multiple sclerosis	1.71e-05	0.000289	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—SPP1—multiple sclerosis	1.7e-05	0.000288	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—SPP1—multiple sclerosis	1.69e-05	0.000286	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCR5—multiple sclerosis	1.66e-05	0.000281	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCR5—multiple sclerosis	1.66e-05	0.000281	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCR5—multiple sclerosis	1.64e-05	0.000278	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TYK2—multiple sclerosis	1.64e-05	0.000278	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL2RA—multiple sclerosis	1.64e-05	0.000277	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL2RA—multiple sclerosis	1.63e-05	0.000277	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL2—multiple sclerosis	1.63e-05	0.000275	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL2—multiple sclerosis	1.62e-05	0.000274	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL2RA—multiple sclerosis	1.62e-05	0.000274	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL2—multiple sclerosis	1.6e-05	0.000272	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—POMC—multiple sclerosis	1.55e-05	0.000262	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—APOE—multiple sclerosis	1.51e-05	0.000256	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—APOE—multiple sclerosis	1.51e-05	0.000255	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—APOE—multiple sclerosis	1.49e-05	0.000253	CbGpPWpGaD
Ipratropium bromide—CHRM3—Metabolism—ALB—multiple sclerosis	1.41e-05	0.000239	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CD80—multiple sclerosis	1.37e-05	0.000232	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL2—multiple sclerosis	1.36e-05	0.000231	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CD80—multiple sclerosis	1.36e-05	0.000231	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling by GPCR—IL6—multiple sclerosis	1.36e-05	0.00023	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CD80—multiple sclerosis	1.35e-05	0.000229	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—POMC—multiple sclerosis	1.3e-05	0.00022	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—POMC—multiple sclerosis	1.29e-05	0.000219	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MMP9—multiple sclerosis	1.29e-05	0.000219	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—POMC—multiple sclerosis	1.28e-05	0.000217	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—CCL2—multiple sclerosis	1.27e-05	0.000215	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—CCL2—multiple sclerosis	1.27e-05	0.000215	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—CCL2—multiple sclerosis	1.25e-05	0.000212	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—MAPK1—multiple sclerosis	1.24e-05	0.000211	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—MAPK1—multiple sclerosis	1.24e-05	0.00021	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—MAPK1—multiple sclerosis	1.23e-05	0.000208	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.17e-05	0.000198	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TYK2—multiple sclerosis	1.15e-05	0.000195	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TYK2—multiple sclerosis	1.15e-05	0.000195	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—STAT3—multiple sclerosis	1.15e-05	0.000194	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TYK2—multiple sclerosis	1.14e-05	0.000193	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—APOE—multiple sclerosis	1.08e-05	0.000183	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MYC—multiple sclerosis	1.07e-05	0.000181	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—TGFB1—multiple sclerosis	1.06e-05	0.00018	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—MAPK1—multiple sclerosis	1.04e-05	0.000177	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL2—multiple sclerosis	9.6e-06	0.000163	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL2—multiple sclerosis	9.57e-06	0.000162	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling by GPCR—IL6—multiple sclerosis	9.56e-06	0.000162	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling by GPCR—IL6—multiple sclerosis	9.52e-06	0.000161	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL2—multiple sclerosis	9.48e-06	0.000161	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling by GPCR—IL6—multiple sclerosis	9.43e-06	0.00016	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—POMC—multiple sclerosis	9.26e-06	0.000157	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MMP9—multiple sclerosis	9.09e-06	0.000154	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MMP9—multiple sclerosis	9.06e-06	0.000153	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MMP9—multiple sclerosis	8.97e-06	0.000152	CbGpPWpGaD
Ipratropium bromide—CYP2D6—Metabolism—ALB—multiple sclerosis	8.44e-06	0.000143	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—STAT3—multiple sclerosis	8.08e-06	0.000137	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—STAT3—multiple sclerosis	8.06e-06	0.000136	CbGpPWpGaD
Ipratropium bromide—CHRM5—Signaling Pathways—IL6—multiple sclerosis	8.02e-06	0.000136	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—STAT3—multiple sclerosis	7.98e-06	0.000135	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MYC—multiple sclerosis	7.51e-06	0.000127	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—TGFB1—multiple sclerosis	7.49e-06	0.000127	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MYC—multiple sclerosis	7.48e-06	0.000127	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—TGFB1—multiple sclerosis	7.47e-06	0.000126	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MYC—multiple sclerosis	7.41e-06	0.000126	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—TGFB1—multiple sclerosis	7.39e-06	0.000125	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—MAPK1—multiple sclerosis	7.35e-06	0.000124	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—MAPK1—multiple sclerosis	7.32e-06	0.000124	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—MAPK1—multiple sclerosis	7.25e-06	0.000123	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—APOE—multiple sclerosis	7.05e-06	0.000119	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—POMC—multiple sclerosis	6.05e-06	0.000103	CbGpPWpGaD
Ipratropium bromide—CHRM1—Signaling Pathways—IL6—multiple sclerosis	5.64e-06	9.56e-05	CbGpPWpGaD
Ipratropium bromide—CHRM3—Signaling Pathways—IL6—multiple sclerosis	5.63e-06	9.53e-05	CbGpPWpGaD
Ipratropium bromide—CHRM2—Signaling Pathways—IL6—multiple sclerosis	5.57e-06	9.44e-05	CbGpPWpGaD
Ipratropium bromide—CYP3A4—Metabolism—ALB—multiple sclerosis	5.52e-06	9.35e-05	CbGpPWpGaD
